News
Stories about the companies we track, gathered daily from UK and European tech press and Google News. Headlines link to the original publisher.
17 storiesMicrobiotica ✕
Clear all- OtherPharmaTimes, 6 days agoMicrobiotica presents phase 1b data for MB097 at ESMO 2026
- OtherPluang, 7 days agoMicrobiotica's MB097 shows safety and promising efficacy in advanced melanoma Phase 1b trial with KEYTRUDA.
- OtherBusiness Weekly, 7 days agoMicrobiotica reigns in Spain as MELODY clinical trial data for advanced melanoma hits right note
- FundingCambridge Independent, 11 days agoMicrobiotica’s £36m Series C raise validates microbiome approach
- OtherInfotechLead, 16 days agoVC funding deals: Estuary Biotherapeutics, Microbiotica, Undecimal Bio
- OtherProactive financial news, 17 days agoMicrobiotica CEO on £36m raise to advance gut treatment into Phase 2; IP Group invests £4m
- FundingEuropean Biotechnology Magazine, 17 days agoMicrobiotica raises £36M to test gut-bacteria capsule in ulcerative colitis
- OtherGlobeNewswire, 18 May 2026Microbiotica Announces Positive Results from its Phase 1b
- OtherPharmaTimes, 18 May 2026Microbiotica reports positive results for MB097 in advanced melanoma
- OtherBusiness Weekly, 17 May 2026Microbiotica reveals new skin cancer therapy success
- OtherThe Clinical Trial Vanguard, 13 Feb 2026Remarkable Results: Microbiotica’s MB310 Colitis Trial
- OtherEuropean Biotechnology Magazine, 11 Feb 2026Microbiotica’s microbiome therapy showed 63% remission in ulcerative colitis phase 1b trial
- OtherBusiness Weekly, 10 Feb 2026COMPOSER-1 trial makes sweet music for Microbiotica
- OtherClinical Trials Arena, 18 Sept 2025Microbiotica concludes recruitment in Phase Ib melanoma trial
- OtherPharmaTimes, 4 Aug 2025Microbiotica completes recruitment for phase 1b ulcerative colitis trial
- OtherBusiness Weekly, 3 Aug 2025Microbiotica set to hit high notes via COMPOSER-1
- LeadershipBusiness Weekly, 9 Jun 2025Microbiotica appoints CIC's Robert Tansley as Chief Medical Officer
